StockData
Amgen Inc logo

Amgen Inc (AMGN) operating KPIs

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)

Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%

Amgen gross-to-Net Sales Deductions — Annual Provisions Charged Against Gross Product Sales ($M) ($M)

Form 10-K Item 7 MD&A Gross-to-Net Sales Deductions Rollforward

Latest, FY2025
41,983
Period ended Dec 31, 2025
Change on a year earlier
+18.8%
35,346 in FY2024
History
12 years
Since FY2014
Sources
10
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGross-to-Net Sales Deductions — Annual Provisions Charged Against Gross Product Sales ($M) ($M)Year on yearSource
FY2025Dec 31, 202541,983+18.8%Form 10-K (amgn-20251231.htm, filed 2026-02-13) ↗
FY2024Dec 31, 202435,346+17.0%Form 10-K (amgn-20251231.htm, filed 2026-02-13) ↗
FY2023Dec 31, 202330,210+18.9%Form 10-K (amgn-20251231.htm, filed 2026-02-13) ↗
FY2022Dec 31, 202225,418+16.2%Form 10-K (amgn-20241231.htm, filed 2025-02-14) ↗
FY2021Dec 31, 202121,879+13.9%Form 10-K (amgn-20231231.htm, filed 2024-02-14) ↗
FY2020Dec 31, 202019,208+26.3%Form 10-K (amgn-20221231.htm, filed 2023-02-09) ↗
FY2019Dec 31, 201915,207+6.4%Form 10-K (amgn-20211231.htm, filed 2022-02-16) ↗
FY2018Dec 31, 201814,286+19.1%Form 10-K (amgn-20201231.htm, filed 2021-02-09) ↗
FY2017Dec 31, 201711,999+24.3%Form 10-K (amgn-12312019x10kq42019.htm, filed 2020-02-12) ↗
FY2016Dec 31, 20169,654+24.7%Form 10-K (amgn-12312018x10kq42018.htm, filed 2019-02-13) ↗
FY2015Dec 31, 20157,741+17.5%Form 10-K (amgn-12312017x10k.htm, filed 2018-02-13) ↗
FY2014Dec 31, 20146,586–Form 10-K (amgn-12312015x10k.htm, filed 2016-02-16) ↗

Breakdown

What makes up gross-to-net sales deductions — annual provisions charged against gross product sales ($m)

Cite this data

StockData. (2026). Amgen Gross-to-Net Sales Deductions — Annual Provisions Charged Against Gross Product Sales ($M) ($M), annual FY2014–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/gtn_prov_tot

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.